Literature DB >> 28161738

A cost analysis of the establishment of a dedicated orthopaedic outpatient injection clinic at a single institution.

M Curtin1, S C O'Neill2, P Keogh2, P Kenny2.   

Abstract

INTRODUCTION: Traditionally orthopaedic injections were performed in a theatre setting. A dedicated outpatient injection clinic was established at our institution to attempt to provide injections more cost effectively. Our aim was to perform a cost analysis of orthopaedic injections performed in theatre, compared to those performed in a dedicated OPD injection clinic.
METHODS: Patient data for all orthopaedic injections performed at a single institution from 2013 to 2014 was obtained using HIPE data. A detailed breakdown of costings for two scenarios; those performed in theatre and those in the dedicated OPD injection clinic was obtained from the hospital finance department. A unit cost per injection for theatre and OPD was derived from this financial information.
RESULTS: A total of 487 injections were performed in 2013, with 491 performed in 2014. 134 (27.5%) injections were performed in the OPD in 2013 compared to 388 (79%) in 2014. The unit cost per injection was calculated as €52.13 for theatre and €23.85 for OPD, this represented a 115% decrease in cost per injection.
CONCLUSION: The creation of a dedicated orthopaedic injection clinic resulted in considerable cost savings at our institution. We propose this may be a more cost-efficient model for delivery of injections in the orthopaedic setting.

Entities:  

Keywords:  Audit; Clinic; Cost; Efficiency; Injection; Outpatient; Saving; TPOT

Mesh:

Year:  2017        PMID: 28161738     DOI: 10.1007/s11845-017-1568-1

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  12 in total

1.  Intra-synovial corticosteroid therapy: a decade of use.

Authors:  J L HOLLANDER; R A JESSAR; E M BROWN
Journal:  Bull Rheum Dis       Date:  1961-01

2.  Corticosteroid injections for osteoarthritis of the knee: meta-analysis.

Authors:  Bruce Arroll; Felicity Goodyear-Smith
Journal:  BMJ       Date:  2004-03-23

Review 3.  The efficacy and duration of intra-articular corticosteroid injection for knee osteoarthritis: a systematic review of level I studies.

Authors:  C Tate Hepper; Jason J Halvorson; Stephen T Duncan; Andrew J M Gregory; Warren R Dunn; Kurt P Spindler
Journal:  J Am Acad Orthop Surg       Date:  2009-10       Impact factor: 3.020

Review 4.  Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis.

Authors:  Raveendhara R Bannuru; Nikola S Natov; Isi E Obadan; Lori L Price; Christopher H Schmid; Timothy E McAlindon
Journal:  Arthritis Rheum       Date:  2009-12-15

5.  Repeated corticosteroid injections into knee joints.

Authors:  H W Balch; J M Gibson; A F El-Ghobarey; L S Bain; M P Lynch
Journal:  Rheumatol Rehabil       Date:  1977-08

Review 6.  Intraarticular drug delivery in osteoarthritis.

Authors:  Nicole Gerwin; Caroline Hops; Andrea Lucke
Journal:  Adv Drug Deliv Rev       Date:  2006-02-23       Impact factor: 15.470

7.  Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial.

Authors:  Jean-Pierre Raynauld; Chris Buckland-Wright; Rupert Ward; Denis Choquette; Boulos Haraoui; Johanne Martel-Pelletier; Imad Uthman; Visithan Khy; Jean-Luc Tremblay; Carole Bertrand; Jean-Pierre Pelletier
Journal:  Arthritis Rheum       Date:  2003-02

8.  Infection in knee replacements after previous injection of intra-articular steroid.

Authors:  A V Papavasiliou; D L Isaac; R Marimuthu; A Skyrme; A Armitage
Journal:  J Bone Joint Surg Br       Date:  2006-03

Review 9.  Viscosupplementation for the treatment of osteoarthritis of the knee.

Authors:  N Bellamy; J Campbell; V Robinson; T Gee; R Bourne; G Wells
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

10.  Septic arthritis in Iceland 1990-2002: increasing incidence due to iatrogenic infections.

Authors:  A J Geirsson; S Statkevicius; A Víkingsson
Journal:  Ann Rheum Dis       Date:  2007-09-27       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.